2.09
Schlusskurs vom Vortag:
$2.19
Offen:
$2.2
24-Stunden-Volumen:
1.15M
Relative Volume:
0.50
Marktkapitalisierung:
$140.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.58M
KGV:
-1.7417
EPS:
-1.2
Netto-Cashflow:
$-9.21M
1W Leistung:
-0.95%
1M Leistung:
-15.04%
6M Leistung:
-16.40%
1J Leistung:
+11.76%
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Vergleichen Sie MBOT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MBOT
Microbot Medical Inc
|
2.09 | 147.08M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
586.24 | 207.41B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.75 | 58.46B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.13 | 39.60B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.47 | 36.63B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.52 | 32.47B | 27.43B | 1.27B | 1.01B | 1.5829 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-03 | Eingeleitet | Roth Capital | Buy |
| 2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Why Microbot Medical Inc. (CY9D) stock is favored by hedge funds2025 Geopolitical Influence & Entry Point Confirmation Signals - ulpravda.ru
Energy Moves: Will Microbot Medical Inc. stock outperform international peers2025 Trading Volume Trends & Growth Oriented Trading Recommendations - ulpravda.ru
Will Microbot Medical Inc. stock benefit from AI adoption2025 Technical Overview & Daily Momentum Trading Reports - ulpravda.ru
Will Microbot Medical Inc. stock outperform international peers2025 Trading Volume Trends & Growth Oriented Trading Recommendations - ulpravda.ru
Why Microbot Medical Inc. stock is a value investor pickTrade Entry Summary & AI Driven Stock Price Forecasts - ulpravda.ru
Why hedge funds are buying Microbot Medical Inc. stock2025 Big Picture & Detailed Earnings Play Strategies - ulpravda.ru
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Is Microbot Medical Inc. stock supported by strong cash flowsPortfolio Return Summary & Advanced Technical Analysis Signals - ulpravda.ru
Portfolio Recap: Is Microbot Medical Inc. stock supported by strong cash flows2025 Dividend Review & Daily Profit Maximizing Tips - ulpravda.ru
Can Microbot Medical Inc. stock hit analyst price targetsDividend Yield Trends & Budget Friendly Investment Plans - ulpravda.ru
Why Microbot Medical Inc stock is a must watch in 2025July 2025 Patterns & Low Drawdown Trading Strategies - moha.gov.vn
Microbot Medical raises funds and anticipates FDA clearance - MSN
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market - MSN
Volume Surge May Signal Institutional Interest in Vascon Engineers LimitedSupport Zone Identification & Low Entry Investment Plans - earlytimes.in
Microbot Medical Inc Stock Analysis and ForecastTrendline Breakouts & Zero-Cost Stock Research by Professionals - earlytimes.in
Can Microbot Medical Inc. stock sustain market leadershipLong-Term Investment Plans & Backtest Your Strategy Before You Risk Money - bollywoodhelpline.com
Microbot Medical (MBOT) price target decreased by 14.29% to 7.65 - MSN
Why Microbot Medical Inc. stock is a must watch in 2025Weekly Loss Report & Weekly Chart Analysis and Trade Guides - DonanımHaber
Will Microbot Medical Inc. (CY9D) stock recover faster than industry2025 Valuation Update & Long-Term Safe Investment Ideas - DonanımHaber
Microbot Medical Inc. (MBOT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Microbot Medical (MBOT) price target decreased by 27.08% to 8.92 - MSN
Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation - Yahoo Finance
Microbot Medical (MBOT) Stock Analysis Report | Financials & Insights - Benzinga
Microbot Medical is a buy, Roth says - Cantech Letter
Microbot Medical (NASDAQ:MBOT) Earns Buy Rating from Analysts at Roth Capital - MarketBeat
Microbot Medical (MBOT) Receives a Buy from Roth MKM - The Globe and Mail
Roth Capital Initiates Coverage on MBOT with a Buy Rating | MBOT Stock News - GuruFocus
Microbot Medical stock initiated with Buy rating at Roth/MKM on LIBERTY system potential - Investing.com Canada
How higher bond yields impact Microbot Medical Inc. (CY9D) stockWeekly Trade Review & Risk Managed Investment Entry Signals - Newser
Roth Capital Initiates Coverage of Microbot Medical (MBOT) with Buy Recommendation - Nasdaq
Is Microbot Medical Inc. stock a dividend growth opportunity2025 Market Outlook & Daily Profit Maximizing Trade Tips - Newser
Can Microbot Medical Inc. (CY9D) stock surprise markets with earnings2025 Market Sentiment & Risk Managed Trade Strategies - Newser
How cyclical is Microbot Medical Inc. (CY9D) stock compared to rivalsWeekly Market Summary & Fast Entry High Yield Tips - Newser
Is POCI a good long term investmentRSI Overbought/Oversold & Low Entry Investment Ideas - earlytimes.in
Emory University Hospital’s Adoption Boosts Microbot Medical’s Market Presence - StocksToTrade
Emory University Adopts Microbot Medical’s Liberty Robotic System - timothysykes.com
HC Wainwright & Co. Reiterates Microbot Medical (MBOT) Buy Recommendation - Nasdaq
Microbot Medical’s Growth: Opportunity or Hype? - timothysykes.com
H.C. Wainwright reaffirms Buy rating on Microbot Medical stock at $12 - Investing.com Canada
MBOT: Analyst Reiterates "Buy" Rating and Price Target at $12 | - GuruFocus
Is Microbot Medical Inc CY9D a good long term investmentValue Traps to Avoid & Exceptional Return Growth - earlytimes.in
Published on: 2025-11-26 22:39:55 - earlytimes.in
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):